Related Experiment Video
Updated: Feb 1, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Diagnosis and classification of infective endocarditis via efficient serum metabolic fingerprint analysis
Ayizekeranmu Yiming1, Xinxin Ma2, Xiran Chen3
1Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, PR China; School of Biomedical Engineering, Institute of Medical Robotics and Shanghai Academy of Experimental Medicine, Shanghai Jiao Tong University, Shanghai, 200030, PR China.
Insights
A new nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI MS) platform offers rapid diagnosis of infective endocarditis (IE) and bacterial classification in minutes. This method bypasses lengthy blood cultures, improving patient outcomes.
Area of Science:
- Cardiovascular Infectious Diseases
- Analytical Chemistry
- Biomarker Discovery
Background:
- Infective endocarditis (IE) is a life-threatening condition with high mortality.
- Current diagnostic criteria (2023 Duke-ISCVID) are complex and time-consuming.
- Blood cultures, while essential, delay diagnosis and treatment by 2-5 days.
Purpose of the Study:
- To develop a rapid, culture-free diagnostic platform for IE.
- To enable simultaneous IE diagnosis and etiological classification.
- To improve timely therapeutic decision-making in IE management.
Main Methods:
- Development of a nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI MS) platform.
- Acquisition of serum metabolic fingerprints (SMFs) using the NPELDI MS platform.
- Integration of machine learning algorithms for data analysis and classification.
Main Results:
- The NPELDI MS platform achieved accurate IE diagnosis with an AUC of 0.882.
- Rapid classification of streptococcal species within 10 minutes.
- Simultaneous IE diagnosis and classification achieved in a single assay, bypassing culture.
Conclusions:
- The NPELDI MS platform offers a rapid, culture-free method for IE diagnosis and classification.
- This technology addresses critical unmet needs in IE management.
- The platform has transformative potential for improving patient outcomes through timely treatment.
Abstract:
Infective endocarditis (IE) continues to pose significant clinical challenges as a life-threatening condition associated with 30 % mortality. The current diagnostic criteria, the 2023 Duke-International Society for Cardiovascular Infectious Diseases (ISCVID) criteria, present diagnostic challenges due to complex processes. Blood culture remains a cornerstone of IE diagnosis, enabling identification of the causative microorganism and guiding targeted antibiotic therapy. However, results typically take 2-5 days, significantly delaying critical treatment decisions. To overcome these limitations, we developed a nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI MS) platform capable of acquiring serum metabolic fingerprints (SMFs). When integrated with machine learning algorithms, this platform achieves accurate IE diagnosis (area under the curve (AUC) = 0.882) and rapid streptococcal classification within 10 min. Notably, our platform enables simultaneous IE diagnosis and classification via a single assay free of culture process. This integrated approach addresses the critical unmet need in IE management, offering transformative potential for timely therapeutic decision-making and improved patient outcomes.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
IR Frequency Region: Fingerprint Region
What is Metabolism?
Classification of Titrimetric Analysis Based on Reaction Types
Titrations between an acid and a base lead to neutralization reactions that form...
Endocarditis III: Medical Management

